Table 1 Summary of patient characteristics
From: Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival
Number | 72 |
Median age (IQR) | 47 (44, 54) years |
Sex | |
Male | 72% |
Female | 28% |
Histology and grade | |
Astro/oligo/oligoastro gr II–III | 54% |
Glioblastoma multiforme gr IV | 46% |
Mutation status | |
TERT promoter only | 58% |
IDH-only | 42% |
Methylation-derived NLR (mdNLR) | |
mdNLR < 4 (%) | 61% |
mdNLR ≥ 4 (%) | 39% |
Length of follow-up | 5–190 months |
Median survival time (IQR) | 29 (13, 65) months |